سعر فليكسوتايد 2 مجم / 2 مل 10 نيبولس 2022

Flixotide nebules, fluticasone propionate 2 mg/2 ml nebuliser suspension, 10 single-dose nebules, by GlaxoSmithKline (imported); inhaled corticosteroid for asthma.

• Adults and adolescents over 16 years: prophylactic management of severe chronic asthma, and treatment of acute exacerbations of asthma.Population: Adults and adolescents over 16 yearsHealth Products Regulatory Authority (HPRA)
• Children and adolescents 4 to 16 years: treatment of acute exacerbations of asthma.Population: Children 4 to 16 yearsHealth Products Regulatory Authority (HPRA)

• Very common: candidiasis of the mouth and throat. Common: hoarseness and contusions. Very rare: hypersensitivity reactions including angioedema and anaphylaxis.International label, same formulation · Health Products Regulatory Authority (HPRA)

• Hypersensitivity to fluticasone propionate or to any of the excipients.International label, same formulation · Health Products Regulatory Authority (HPRA)

• Nebulised fluticasone propionate is not a substitute for injectable or oral corticosteroids in an emergency.International label, same formulation · Health Products Regulatory Authority (HPRA)
• When a face mask is used, the skin under the mask may become thin (atrophy); protect it with a barrier cream or wash the face after treatment.International label, same formulation · Health Products Regulatory Authority (HPRA)
• Paradoxical bronchospasm may occur; treat immediately with a fast-acting bronchodilator and stop the medicine.International label, same formulation · Health Products Regulatory Authority (HPRA)

• Ritonavir and other strong CYP3A4 inhibitorsCan greatly increase systemic fluticasone propionate exposure, causing Cushing's syndrome and adrenal suppression; avoid unless the benefit outweighs the risk.Health Products Regulatory Authority (HPRA)

• Use in pregnancy only if the expected benefit to the mother outweighs any possible risk to the fetus.International label, same formulation · Health Products Regulatory Authority (HPRA)
• Use in breastfeeding only if the expected benefit to the mother outweighs any possible risk to the child.International label, same formulation · Health Products Regulatory Authority (HPRA)

• Fluticasone propionate: Glucocorticoid with potent anti-inflammatory activity in the lungs or nasal mucosa at recommended doses, with low systemic exposure (UK Flixotide/Flixonase SmPCs, section 5.1).